Sanofi Wins EU Approval
Sanofi's multiple sclerosis drug Cenrifki approved in Europe despite FDA rejection
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
SNY: Japan Approves Wayrilz
Sanofi's Wayrilz is approved in Japan for persistent or chronic immune thrombocytopenia based on the LUNA 3 Phase 3 study
Sanofi: Wayrilz Approved
Sanofi's Wayrilz is approved in Japan for immune thrombocytopenia based on the Luna 3 Phase 3 study